Inhibition of human lung fibroblast functions by roflumilast N-oxide Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006
Roflumilast N-oxide, a PDE4 inhibitor, curbs bleomycin-induced lung fibroblast activation in vitro Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011
The PDE4 inhibitor roflumilast N-oxide partly reversed TGFß1-induced changes in collagen I and E-cadherin expression in human airway epithelial cells Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008
Roflumilast N-oxide (RNO) alleviates from RSV-induced loss of ciliated cells and enhanced MUC5AC in differentiated human bronchial epithelial cells (D-HBE) Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010
Dexamethasone and formoterol modulate human rhinovirus induced MMP-9 expression Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010
LATE-BREAKING ABSTRACT: Roflumilast and its active metabolite inhibit LPS-induced cytokines production from human parenchymal and bronchial explants: interaction with formoterol Source: Annual Congress 2009 - Airway cell biology Year: 2009
Proteoglycan production in cultured human lung fibroblasts is synergistcally inhibited by combination of budesonide and formoterol Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003
Inhibition of VEGF and MMP-9 production by Pregabalin in human immunocompetent cells in vitro Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
Guaifenesin suppresses MUC5AC content and secretion in human airway epithelial cell cultures: Comparison with N-acetylcysteine and ambroxol Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012
Tiotropium enhances the inhibitory effect of the long acting β2-agonist olodaterol on the release of IL-6 and IL8 by primary human lung fibroblasts of asthma patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Tiotropium bromide inhibits acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro Source: Eur Respir J 2005; 26: Suppl. 49, 121s Year: 2005
TGFβ-induced proteoglycan production and α-smooth muscle actin expression in cultured human lung fibroblasts is inhibited by combination of budesonide and formoterol Source: Eur Respir J 2004; 24: Suppl. 48, 251s Year: 2004
Roflumilast and its active metabolite roflumilast N-oxide do not interact with R- and S-warfarin Source: Eur Respir J 2003; 22: Suppl. 45, 103s Year: 2003
Naftopidil, a selective a1 adrenoceptor antagonist, inhibits the growth of lung fibroblasts and attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017
Formoterol protects against platelet-activating factor-induced lung function abnormalities in asthma Source: Eur Respir J 2001; 18: Suppl. 33, 515s Year: 2001
Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013
Effects of aclidinium on human lung fibroblast activation in vitro Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011
Effect of roflumilast, a PDE4 inhibitor, on ciliary beat frequency in human nasal epithelial cells Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008
Synergistic effect of cysteinyl-leukotrienes and epidermal growth factor on human lung fibroblast mitogenesis Source: Eur Respir J 2005; 26: Suppl. 49, 340s Year: 2005
Roflumilast N-oxide (RNO) attenuates epithelial-mesenchymal transition (EMT) in differentiated human bronchial epithelial cells (D-HBE) Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010